Sign up for news & promotions:
SMAD1 Primary Antibody
|Aliases||BSP1; JV41; JV4-1; MADH1; MADR1; SMAD1|
|Formulation||The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen. Liquid in PBS containing 50% glycerol and 0.03% sodium azide.|
|Immunogen||Synthesized peptide derived from internal of human SMAD1.|
|Shipping Information||This product will ship in a box containing blue ice at a temperature of 4°C. Learn More|
|Species Reactivity||Human, Mouse, Monkey|
|IHC_P (Immunohistochemistry)||1/200 - 1/1000|
|WB (Western Blot)||1/500 - 1/2000|
Figure 1: Western blot analysis using SMAD1 Rabbit pAb against A431 (1) and HEK293 (2) cell lysate.
Figure 2: Immunohistochemical analysis of paraffin-embedded larynx cancer tissues (left) and colon cancer tissues (right) using SMAD1 Rabbit pAb with DAB staining.
|Description||The protein encoded by this gene belongs to the SMAD, a family of proteins similar to the gene products of the Drosophila gene 'mothers against decapentaplegic' (Mad) and the C. elegans gene Sma. SMAD proteins are signal transducers and transcriptional modulators that mediate multiple signaling pathways. This protein mediates the signals of the bone morphogenetic proteins (BMPs), which are involved in a range of biological activities including cell growth, apoptosis, morphogenesis, development and immune responses. In response to BMP ligands, this protein can be phosphorylated and activated by the BMP receptor kinase. The phosphorylated form of this protein forms a complex with SMAD4, which is important for its function in the transcription regulation. This protein is a target for SMAD-specific E3 ubiquitin ligases, such as SMURF1 and SMURF2, and undergoes ubiquitination and proteasome-mediated degradation. Alternatively spliced transcript variants encoding the same protein have been observed.|
|References (references)||1. Cancer Biol Ther. 2008 Oct;7(10):1694-9.
2. J Med Genet. 2009 May;46(5):331-7.
3. EMBO J. 2009 Jun 3;28(11):1537-50.